Proven Solutions for Centralized Cardiac Safety Trials

In the world of Cardiac Safety, data is king. As the leading cause of drug delays or withdrawals, ERT understands your need for the highest quality patient data, on time and in real-time. We deliver consistent algorithms, training, analysis, and rigorous QA/QC with multiple eyes on the data. Proactive project management and cost-conscious price assurance maximizes study ROI for our sponsor and CRO partners. Our approach is simple: centralized collection, interpretation and distribution of ECG and ambulatory blood pressure data and images to rule out errors from the very beginning. Our world renowned consulting experts are relied upon for their insights and regulatory authority.

Cardiac-SafetyT

Proven Solutions for Centralized Cardiac Safety Trials

Our approach is simple: centralized collection, interpretation and distribution of ECG and ambulatory blood pressure data and images to rule out errors from the very beginning. Our world renowned consulting experts are relied upon for their insights and regulatory authority.

Cardiac-SafetyT

Over 435 new drug approvals across 6,500 studies with 1.5 million patients, supporting more than 200,000 sites in 114 countries

Over 435 new drug approvals across 6,500 studies with 1.5 million patients, supporting more than 200,000 sites in 114 countries

Enroll more patients with precise ECG measurement
What impact do inaccurate site machine ECGs have on your study?

Consulting: Decades of cardiology and technology thought leadership and regulatory experience to improve clinical trial protocols, increase data accuracy and mitigate risk in cardiac safety studies.

Phase I & Thorough QT Studies: Optimize protocol design, fulfill requirements for TQT studies, support Phase I CPUs in intense ECG studies with PK-PD analysis, and ensure accurate regulatory submission.

Phase II-IV: Go beyond differing site devices, varying interpretations, and paper to achieve better data quality and integration, reduced burden and risk, and lower cost to protect your patients and compounds.

Innovative Solutions: Leverage our ongoing innovation in devices, algorithms, integrated endpoint collection, risk monitoring, technology, process optimization, and future trial strategies.

Not every heartbeat is the same.
Leverage EXPERT QT™ for our experience, unique analytics and
to potentially replace a Thorough QT study…

Cardiac_WC_ctaF1